ABBOTT AXSYM SYSTEM 7A83-01

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2009-10-12 for ABBOTT AXSYM SYSTEM 7A83-01 manufactured by Abbott Manufacturing, Inc..

Event Text Entries

[1173543] The account stated that the axsym analyzer has generated a false negative cmv igm result on a patient sample. The index value was negative between 0. 268-0. 356. The sample was then tested by the vidas method, and the result was positive at 1. 85. The cmv igg result for this patient was also positive. There was no adverse impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[8283227] (b) (4) this is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[8406138] (b)(4). An fsr found the solution #4 pump was dispensing about 50% of expected volume. The fsr replaced the pump. The fsr found the processing probe was dripping during a flush, and the processing probe failed a probe calibration. The fsr replaced the processing side syringe valve. The fsr ran a successful processing probe calibration, and a control run to verify the analyzer performance. The complaint text notes the probable causes of the erratic results issue was buffer pump and syringe valve failures. The fsr documented that the buffer pump and syringe valve were replaced as hard failures and were worn out from normal use. A service history review found no additional complaints have been documented for axsym (b)(6) since the fsr serviced the axsym, and replaced the buffer pump and syringe valve. A level 3 investigation was opened on (b)(6), 2001 to reduce the occurrence of inconsistent results on the axsym analyzer. The investigation determined inconsistent results were generated if the operator failed to follow assay specific package inserts and/or the abbott axsym system operations manual concerning sample handling, loading reagent packs, probe crash recovery, weekly maintenance and the loading of bulk solutions. As part of level 3 investigation, a product information letter (pi (b)(6) 2001) was issued to reinforce the importance of following instructions provided in the abbott axsym system operations manual, addendums and assay-specific package inserts in order to ensure optimum performance of the axsym system. An abbott metrics report for the axsym analyzer was reviewed and no adverse trends were found to have been identified for cmv igm assay erratic results generation.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2009-00501
MDR Report Key1500623
Report Source01,05
Date Received2009-10-12
Date of Report2009-09-21
Date of Event2009-09-15
Date Mfgr Received2009-10-19
Device Manufacturer Date1995-04-28
Date Added to Maude2010-03-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT MANUFACTURING, INC.
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameABBOTT AXSYM SYSTEM
Generic NameAUTOMATED IMMUNOASSAY ANALYZER
Product CodeOMI
Date Received2009-10-12
Catalog Number7A83-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING, INC.
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2009-10-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.